Ascendis Pharma, Inc.
500 Emerson Street
Palo Alto
CA
94301
United States
Tel: 650-352-8389
Fax: 650-618 -592
Website: http://www.ascendispharma.com/
Email: info@ascendispharma.com
146 articles with Ascendis Pharma, Inc.
-
Ascendis Pharma A/S Appoints Martin Auster, M.D., As Chief Business Officer
6/2/2014
-
Ascendis Pharma A/S Announces The Appointment Of Thomas P. Soloway As Chief Financial Officer
1/10/2014
-
United Therapeutics Corporation Announces Collaboration With Ascendis Pharma A/S to Develop Self-Injectable Treprostinil for Pulmonary Arterial Hypertension
9/20/2012
-
Novo Nordisk A/S, Eli Lilly and Company, And Novartis AG Said to Bid for Ascendis Pharma A/S; Offer is Rumored to be About $400 Million
8/3/2010
-
Ascendis Pharma A/S Initiates Phase I Clinical Study Of ACP-001, A Once-Weekly Human Growth Hormone Product
11/10/2009
-
Ascendis Pharma A/S Completes €17.6 Million Series-A Financing
12/14/2007